Stay updated on Gantenerumab in Prodromal Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.

Latest updates to the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, replaced by a minimal error view with a Home link.SummaryDifference18%

- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s revision tag was updated from v3.6.5 to v3.6.6, signaling a minor update to the page’s revision history. This change does not alter visible content or user-facing functionality.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor metadata/version update to the page.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision: v3.6.4 now appears on the page, replacing the previous v3.6.3. This denotes a minor update to the page's revision metadata rather than substantive changes to the study details.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page revision tag was updated to v3.6.3, replacing the previous v3.6.2, signaling a version update to the page or its documents.SummaryDifference0.0%

- Check94 days agoChange DetectedAdded a new 2024 publication citation about long-term safety of gantenerumab (Marguerite RoAD) to the Publications section. Updated the revision tag from v3.6.0 to v3.6.2.SummaryDifference0.0%

Stay in the know with updates to Gantenerumab in Prodromal Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.